Dr. Brendan Carvalho shares insights from a study comparing Accuro’s accuracy to other ultrasound devices for neuraxial anesthesia. He explains how both Accuro and larger ultrasound systems reliably predict the point of loss of resistance, particularly in patients with challenging anatomy, such as those with obesity, scoliosis, or previous spine surgery. Dr. Carvalho highlights Accuro’s key advantages, including its portability, 3D navigation, and unique skin-marking feature, which together enhance precision and usability in both clinical and teaching environments.
Recent Posts
- RIVANNA’s 2025 Year in Review: Medical Imaging Innovation Across U.S. Healthcare
- Global Neuraxial Practices: How Regional Differences Shape Patient Outcomes
- RIVANNA announces FDA clearance of Accuro 3S Needle Guide Kit
- Advancing Obstetric Anesthesia: Dr. Steven Garber on the Real-World Power of Accuro 3S
- Building Healthcare Equity in Modern Health Systems